• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促进前列腺癌的致癌作用和致死性进展。

promotes oncogenesis and lethal progression of prostate cancer.

机构信息

David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.

Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139.

出版信息

Proc Natl Acad Sci U S A. 2024 Sep 3;121(36):e2405543121. doi: 10.1073/pnas.2405543121. Epub 2024 Aug 27.

DOI:10.1073/pnas.2405543121
PMID:39190349
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11388324/
Abstract

Higher levels of aneuploidy, characterized by imbalanced chromosome numbers, are associated with lethal progression in prostate cancer. However, how aneuploidy contributes to prostate cancer aggressiveness remains poorly understood. In this study, we assessed in patients which genes on chromosome 8q, one of the most frequently gained chromosome arms in prostate tumors, were most strongly associated with long-term risk of cancer progression to metastases and death from prostate cancer (lethal disease) in 403 patients and found the strongest candidate was cohesin subunit gene, , with an odds ratio of 3.7 (95% CI 1.8, 7.6) comparing the highest vs. lowest tertiles of mRNA expression and adjusting for overall aneuploidy burden and Gleason score, both strong prognostic factors in primary prostate cancer. Studying prostate cancer driven by the oncogenic fusion, found in about half of all prostate tumors, we found that increased alleviated toxic oncogenic stress and DNA damage caused by oncogene expression. Data from both organoids and patients indicate that increased RAD21 thereby enables aggressive tumors to sustain tumor proliferation, and more broadly suggests one path through which tumors benefit from aneuploidy.

摘要

高水平的非整倍体,其特征是染色体数量不平衡,与前列腺癌的致死性进展相关。然而,非整倍体如何导致前列腺癌侵袭性仍然知之甚少。在这项研究中,我们评估了 403 名患者中,染色体 8q 上的哪些基因与前列腺肿瘤中最常获得的染色体臂之一,与癌症进展为转移和死于前列腺癌(致命疾病)的长期风险最密切相关,发现最强的候选基因是黏合蛋白亚基基因 ,与 mRNA 表达最高与最低三分位相比,其比值比为 3.7(95%CI1.8,7.6),并调整了整体非整倍体负担和 Gleason 评分,这两个都是原发性前列腺癌的强预后因素。研究发现,在大约一半的前列腺肿瘤中存在的致癌融合驱动的前列腺癌,发现增加了 减轻了致癌基因表达引起的毒性致癌应激和 DNA 损伤。来自类器官和患者的数据表明,RAD21 的增加使侵袭性肿瘤能够维持肿瘤增殖,并更广泛地表明肿瘤从非整倍体中获益的一条途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90f1/11388324/b385e3e88762/pnas.2405543121fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90f1/11388324/0e151b3cbe2e/pnas.2405543121fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90f1/11388324/e47e4ca4d2cc/pnas.2405543121fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90f1/11388324/b71fca412647/pnas.2405543121fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90f1/11388324/b385e3e88762/pnas.2405543121fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90f1/11388324/0e151b3cbe2e/pnas.2405543121fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90f1/11388324/e47e4ca4d2cc/pnas.2405543121fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90f1/11388324/b71fca412647/pnas.2405543121fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90f1/11388324/b385e3e88762/pnas.2405543121fig04.jpg

相似文献

1
promotes oncogenesis and lethal progression of prostate cancer.促进前列腺癌的致癌作用和致死性进展。
Proc Natl Acad Sci U S A. 2024 Sep 3;121(36):e2405543121. doi: 10.1073/pnas.2405543121. Epub 2024 Aug 27.
2
Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis.TMPRSS2-ERG 与 BAF 染色质重塑复合物的结合介导前列腺癌的发生。
Mol Cell. 2018 Aug 16;71(4):554-566.e7. doi: 10.1016/j.molcel.2018.06.040. Epub 2018 Aug 2.
3
is a driver of chromosome 8 gain in Ewing sarcoma to mitigate replication stress.是伊文肉瘤中 8 号染色体获得的驱动因素,以减轻复制应激。
Genes Dev. 2021 Apr 1;35(7-8):556-572. doi: 10.1101/gad.345454.120. Epub 2021 Mar 25.
4
The Thoc1 ribonucleoprotein and prostate cancer progression.Thoc1核糖核蛋白与前列腺癌进展
J Natl Cancer Inst. 2014 Oct 8;106(11). doi: 10.1093/jnci/dju306. Print 2014 Nov.
5
Genetic interaction between Tmprss2-ERG gene fusion and Nkx3.1-loss does not enhance prostate tumorigenesis in mouse models.Tmprss2-ERG基因融合与Nkx3.1缺失之间的遗传相互作用不会增强小鼠模型中的前列腺肿瘤发生。
PLoS One. 2015 Mar 17;10(3):e0120628. doi: 10.1371/journal.pone.0120628. eCollection 2015.
6
Aneuploidy drives lethal progression in prostate cancer.非整倍体导致前列腺癌的致命进展。
Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11390-11395. doi: 10.1073/pnas.1902645116. Epub 2019 May 13.
7
The TMPRSS2-ERG Gene Fusion Blocks XRCC4-Mediated Nonhomologous End-Joining Repair and Radiosensitizes Prostate Cancer Cells to PARP Inhibition.TMPRSS2-ERG基因融合阻断XRCC4介导的非同源末端连接修复并使前列腺癌细胞对PARP抑制敏感。
Mol Cancer Ther. 2015 Aug;14(8):1896-906. doi: 10.1158/1535-7163.MCT-14-0865. Epub 2015 May 29.
8
Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer.多灶性前列腺癌背景下TMPRSS2-ERG融合基因的定位
Mod Pathol. 2008 Feb;21(2):67-75. doi: 10.1038/modpathol.3800981. Epub 2007 Dec 7.
9
DNA Damage Promotes TMPRSS2-ERG Oncoprotein Destruction and Prostate Cancer Suppression via Signaling Converged by GSK3β and WEE1.DNA 损伤通过 GSK3β 和 WEE1 信号交汇促进 TMPRSS2-ERG 癌蛋白降解和前列腺癌抑制。
Mol Cell. 2020 Sep 17;79(6):1008-1023.e4. doi: 10.1016/j.molcel.2020.07.028. Epub 2020 Aug 31.
10
Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease.胰岛素样生长因子/胰岛素受体在前列腺癌组织中的表达与向致死性疾病的进展。
Carcinogenesis. 2018 Dec 31;39(12):1431-1437. doi: 10.1093/carcin/bgy112.

引用本文的文献

1
Genomic landscape and homologous recombination repair deficiency signature in stage I-III and de novo stage IV primary breast cancers.I-III期及初发IV期原发性乳腺癌的基因组格局及同源重组修复缺陷特征
Oncologist. 2025 May 8;30(5). doi: 10.1093/oncolo/oyaf089.

本文引用的文献

1
Association of self-identified race and genetic ancestry with the immunogenomic landscape of primary prostate cancer.自报的种族和遗传血统与原发性前列腺癌的免疫基因组景观的关联。
JCI Insight. 2023 Feb 8;8(3):e162409. doi: 10.1172/jci.insight.162409.
2
Chromosome 8q arm overexpression is associated with worse prostate cancer prognosis.8q 染色体臂过表达与前列腺癌预后不良相关。
Urol Oncol. 2023 Feb;41(2):106.e17-106.e23. doi: 10.1016/j.urolonc.2022.10.002. Epub 2022 Nov 15.
3
RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer.
RAD21 扩增通过表观遗传抑制干扰素信号转导,促进卵巢癌的免疫逃逸。
J Clin Invest. 2022 Nov 15;132(22):e159628. doi: 10.1172/JCI159628.
4
Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.前列腺癌研究的临床注释:定义数据元素、创建可重复的分析流程以及评估数据质量。
Prostate. 2022 Aug;82(11):1107-1116. doi: 10.1002/pros.24363. Epub 2022 May 10.
5
Effects of aneuploidy on cell behaviour and function.非整倍体对细胞行为和功能的影响。
Nat Rev Mol Cell Biol. 2022 Apr;23(4):250-265. doi: 10.1038/s41580-021-00436-9. Epub 2022 Jan 5.
6
p53 Immunohistochemistry to Identify Very High-risk Primary Prostate Cancer: A Prospective Cohort Study with Three Decades of Follow-up.p53免疫组化用于识别极高风险原发性前列腺癌:一项长达三十年随访的前瞻性队列研究
Eur Urol Oncol. 2023 Feb;6(1):110-112. doi: 10.1016/j.euo.2021.12.003. Epub 2021 Dec 27.
7
Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays.使用组织微阵列研究肿瘤生物标志物中批次效应的程度、影响和缓解。
Elife. 2021 Dec 23;10:e71265. doi: 10.7554/eLife.71265.
8
Cohesin regulates homology search during recombinational DNA repair.黏合蛋白调控重组 DNA 修复过程中的同源搜索。
Nat Cell Biol. 2021 Nov;23(11):1176-1186. doi: 10.1038/s41556-021-00783-x. Epub 2021 Nov 8.
9
Differences in Prostate Cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable Cancer Risk Factors, and Clinical Factors.基于自我报告种族的前列腺癌基因组差异:遗传背景、可改变的癌症风险因素和临床因素的贡献。
Clin Cancer Res. 2022 Jan 15;28(2):318-326. doi: 10.1158/1078-0432.CCR-21-2577. Epub 2021 Oct 19.
10
Assessment of MYC/PTEN Status by Gene-Protein Assay in Grade Group 2 Prostate Biopsies.通过基因-蛋白检测评估 2 级前列腺活检组织中 MYC/PTEN 的状态。
J Mol Diagn. 2021 Aug;23(8):1030-1041. doi: 10.1016/j.jmoldx.2021.05.006. Epub 2021 May 29.